Aurum Resources Ltd P/E
Cos'è P/E di Aurum Resources Ltd?
P/E di Aurum Resources Ltd è N/A
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Materials settore su ASX rispetto a Aurum Resources Ltd
Cosa fa Aurum Resources Ltd?
Aurum Resources Limited focuses on operating in the exploration and development business in Australia. It explores for gold, vanadium titanomagnetite, and nickel cobalt metals. Its projects include Penny South gold, the Unaly Hill South, and the Ryan's Find projects located in Western Australia. The company was incorporated in 2021 and is based in West Perth, Australia.
Aziende con p/e simili a Aurum Resources Ltd
- Reliq Health Technologies ha P/E di N/A
- Dyadic International ha P/E di N/A
- Stuhini Exploration ha P/E di N/A
- Citizen Stash Cannabis Corp ha P/E di N/A
- Qurate Retail Inc ha P/E di N/A
- Arizona Sonoran Copper ha P/E di N/A
- Aurum Resources Ltd ha P/E di N/A
- Aldoro Resources ha P/E di N/A
- AML3D ha P/E di N/A
- Australian Unity Office Fund ha P/E di N/A
- Amryt Pharma plc ha P/E di N/A
- Dubber ha P/E di N/A
- NetScientific plc ha P/E di N/A